News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
833,413 Results
Type
Article (85696)
Company Profile (747)
Press Release (746970)
Section
Business (232293)
Career Advice (4108)
Deals (39653)
Drug Delivery (120)
Drug Development (90705)
Employer Resources (194)
FDA (17988)
Job Trends (17275)
News (395671)
Policy (39632)
Tag
Academia (2975)
Alliances (56524)
Alzheimer's disease (1358)
Approvals (17897)
Artificial intelligence (177)
Bankruptcy (394)
Best Places to Work (12551)
Biotechnology (512)
Breast cancer (182)
Cancer (1392)
Cardiovascular disease (120)
Career advice (3514)
Cell therapy (308)
Clinical research (71878)
Collaboration (481)
Compensation (253)
COVID-19 (2810)
C-suite (119)
Data (1385)
Diabetes (178)
Diagnostics (6710)
Earnings (94801)
Employer resources (167)
Events (127260)
Executive appointments (376)
FDA (18645)
Funding (434)
Gene therapy (219)
GLP-1 (710)
Government (5053)
Healthcare (20735)
Infectious disease (2907)
Inflammatory bowel disease (125)
Interviews (807)
IPO (17618)
Job creations (5180)
Job search strategy (2855)
Layoffs (492)
Legal (10048)
Lung cancer (205)
Manufacturing (222)
Medical device (14446)
Medtech (14451)
Mergers & acquisitions (22129)
Metabolic disorders (500)
Neuroscience (1705)
NextGen Class of 2024 (7658)
Non-profit (5067)
Northern California (1670)
Obesity (288)
Opinion (245)
Patents (123)
People (64301)
Pharmaceutical (152)
Phase I (22140)
Phase II (31211)
Phase III (23531)
Pipeline (513)
Postmarket research (3547)
Preclinical (10002)
Radiopharmaceuticals (259)
Rare diseases (277)
Real estate (7373)
Regulatory (26062)
Research institute (2642)
Resumes & cover letters (648)
Southern California (1461)
Startups (4276)
United States (15824)
Vaccines (663)
Weight loss (228)
Date
Today (177)
Last 7 days (713)
Last 30 days (3151)
Last 365 days (38327)
2024 (37079)
2023 (42568)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (230)
Asia (49453)
Australia (8712)
California (3872)
Canada (1411)
China (304)
Colorado (177)
Connecticut (190)
Europe (113255)
Florida (523)
Georgia (139)
Illinois (447)
Indiana (235)
Maryland (669)
Massachusetts (3111)
Michigan (188)
Minnesota (310)
New Jersey (1113)
New York (1087)
North Carolina (872)
Northern California (1670)
Ohio (154)
Pennsylvania (924)
South America (1647)
Southern California (1461)
Texas (569)
Utah (112)
Washington State (426)
There are 833,413 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PolyPid Announces Research and Development Collaboration with ImmunoGenesis Leveraging PLEX Technology to Enhance Cancer Immunotherapy
December 12, 2024
·
4 min read
Press Releases
BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®
December 12, 2024
·
10 min read
Press Releases
Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports Phase 2 Trial for Obesity Currently Enrolling with U.S. Patient Cohort to be Added in 2025. Scilex Bio Reports Positive Results from the Recently Completed Phase 1 Trials Conducted by NeuroBiogen for KDS2010, a Novel Oral Tablet Recently Synthesized Potent, Selective, and Reversible Monoamine Oxidase B inhibitor
December 12, 2024
·
14 min read
Press Releases
Reunion Neuroscience Presented RE104 Phase 1 Data at the 2024 American College of Neuropsychopharmacology (ACNP) 63rd Annual Meeting
December 12, 2024
·
1 min read
Press Releases
Prospective Clinical Utility Study of Lucid Diagnostics’ EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication
December 12, 2024
·
5 min read
Press Releases
Provectus Biopharmaceuticals Launches VisiRose, Provectus’s Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology
December 12, 2024
·
5 min read
Press Releases
Nature Biotechnology | Generative Chemistry Enables Insilico to Develop Gut-Restricted PHD Inhibitors Promising for Intestinal Mucosal Barrier Repair and Immunomodulation
December 12, 2024
·
6 min read
Press Releases
DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old
December 12, 2024
·
11 min read
Press Releases
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025
December 12, 2024
·
16 min read
Press Releases
Io Therapeutics, Inc., announces presentation of data from studies of its RAR gamma agonist compound IRX5010 in treatment of a mouse model of triple negative breast cancer, demonstrating combination treatment effects with an anti-PDL-1 monoclonal antibody checkpoint inhibitor
December 12, 2024
·
3 min read
1 of 83,342
Next
